Immunotherapeutic options for the treatment of neuroblastoma: an analysis of natural killer cell and gamma delta T cell based immunotherapy
Neuroblastoma is an aggressive solid tumor that develops from immature cells of the nervous system and is almost exclusively diagnosed in infants and young children. Over the past decade a multitude of immune based therapies have been explored as therapeutic candidates for patients with neuroblast...
Main Author: | Bixby, Catherine Elizabeth |
---|---|
Language: | en_US |
Published: |
2016
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/14691 |
Similar Items
-
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells
by: Kevin O. McNerney, et al.
Published: (2020-05-01) -
Role of Natural Killer and Gamma-Delta T cells in West Nile Virus Infection
by: Thomas Welte, et al.
Published: (2013-09-01) -
Natural Killer Cells and Neuroblastoma: tumor recognition, escape mechanisms and possible novel immunotherapeutic approaches
by: Cristina eBottino, et al.
Published: (2014-02-01) -
Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local
by: C. David Pauza, et al.
Published: (2018-06-01) -
Potentiation of Natural Killer Cells for Cancer Immunotherapy: A Review of Literature
by: Lacy E. Lowry, et al.
Published: (2017-09-01)